255 related articles for article (PubMed ID: 2403935)
1. Lipids, cardiovascular disease, and oral contraceptives: a practical perspective.
Upton GV
Fertil Steril; 1990 Jan; 53(1):1-12. PubMed ID: 2403935
[TBL] [Abstract][Full Text] [Related]
2. The metabolic impact of oral contraceptives.
Krauss RM; Burkman RT
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptives and cardiovascular risk. Taking a safe course of action.
Derman RJ
Postgrad Med; 1990 Sep; 88(4):119-22. PubMed ID: 2204902
[TBL] [Abstract][Full Text] [Related]
4. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
5. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L
Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417
[TBL] [Abstract][Full Text] [Related]
6. The role of triphasic levonorgestrel in oral contraception: a review of metabolic and hemostatic effects.
Lachnit-Fixson U
Gynecol Endocrinol; 1996 Jun; 10(3):207-18. PubMed ID: 8862497
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
Crook D; Godsland IF; Wynn V
Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
[TBL] [Abstract][Full Text] [Related]
8. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
Bakir R; Hilliquin P
Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
[TBL] [Abstract][Full Text] [Related]
9. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
LaRosa JC
Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
[TBL] [Abstract][Full Text] [Related]
10. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
Falsetti L; Pasinetti E
Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
13. The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins.
Wynn V; Niththyananthan R
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):766-71. PubMed ID: 6801982
[TBL] [Abstract][Full Text] [Related]
14. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
15. Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study.
Greenlund KJ; Webber LS; Srinivasan S; Wattigney W; Johnson C; Berenson GS
Ann Epidemiol; 1997 Nov; 7(8):561-7. PubMed ID: 9408552
[TBL] [Abstract][Full Text] [Related]
16. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives and lipids.
Fotherby K
BMJ; 1989 Apr; 298(6680):1049-50. PubMed ID: 2497884
[TBL] [Abstract][Full Text] [Related]
18. A norgestimate-containing oral contraceptive: review of clinical studies.
Kafrissen ME
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1196-202. PubMed ID: 1415446
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptives: a reassessment.
Derman R
Obstet Gynecol Surv; 1989 Sep; 44(9):662-8. PubMed ID: 2671844
[TBL] [Abstract][Full Text] [Related]
20. Adverse influences of alcohol, tobacco, and oral contraceptive use on cardiovascular risk factors during transition to adulthood.
Croft JB; Freedman DS; Cresanta JL; Srinivasan SR; Burke GL; Hunter SM; Webber LS; Smoak CG; Berenson GS
Am J Epidemiol; 1987 Aug; 126(2):202-13. PubMed ID: 3605049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]